Mutation analysis of MFSD8 in an amyotrophic lateral sclerosis cohort from mainland China
Whole exome sequencing identified two rare deleterious variants c.343G>A (p.V115M) and c.695T>C (p.L232P) in frontotemporal dementia‐associated gene MFSD8 in amyotrophic lateral sclerosis (ALS) patients. The rare variant c.695T>C (p.L232P) is a novel variant that affecting the protein structure and may be a candidate risk factor of ALS.
Recent studies have suggested that rare variants in MFSD8 contribute to risk for frontotemporal dementia (FTD). Considering the common underlying pathogenesis and the shared genetic risk between amyotrophic lateral sclerosis (ALS) and FTD, we screened the coding region of MFSD8 in 551 unrelated patients with ALS (510 unrelated sporadic ALS and 41 familial ALS probands) from mainland China by whole‐exome sequencing to assess its mutation frequency in patients with ALS and evaluate its association. Two rare deleterious variants, c.343G>A (p. V115M) and c.695T>C (p.L232P), were identified in this study. The variant c.695T>C (p.L232P) has not been previously reported and the carrier of this variant exhibits a relatively younger age of disease onset. Our studies provide some independent evidence showing that the rare variant p.L232P in MFSD8 might be a candidate risk factor for ALS. However, the relatively small sample size and the lack of patient‐derived cells limit the power of the genetic exploration of this study, further robust multicenter studies with larger sizes and biological experiments with patient‐derived cells are needed to elucidate the pathogenesis of the rare variant in MFSD8 in ALS.